Response to: Frailty is Associated with Increased Rates of Acute Cellular Rejection Within 3 Months After Liver Transplantation.
Up to 1 in 5 patients with end stage liver disease in the United States are frail.1 Emerging data suggests that frailty is more than simple deconditioning, but rather a distinct phenotype accompanied by immune dysregulation.2-5 Within this context, Fozouni et al. investigated the association of frailty and acute cellular rejection (ACR) in a retrospective, single-center cohort study of 241 liver transplant patients.6 After controlling for a number of potential confounders using bivariate logistic regression modeling, the authors found frailty was strongly associated with ACR in the 90-day period following transplantation. Most importantly, the authors found the same association after adjusting for changes in immunosuppression dose, which occurs at disproportionately high rates among frail population.